Advances in Lung Cancer Basic and Translational Research in 2025-Overview and Perspectives Focusing on NSCLC


Por: Mascaux, C, Sen, T, Sanchez-Cespedes, M, Ortiz-Cuaran, S, Bossé, Y, Dammeijer, F, Cavic, M, Barr, MP, Arulananda, S, Armisen, R, Berger, AH, Bianchi, F, Carbone, DP, Cerciello, F, Lockwood, WW, Mitsudomi, T, Ohara, S, Politi, K, Qin, SD, Roisman, LC, Samstein, R, Skoulidis, F, Tan, AC, Thomas, A, Zhang, JJ, Wynes, MW, John, T and Tsao, MS

Publicada: 1 oct 2025 Ahead of Print: 1 oct 2025
Resumen:
Basic and translational research in lung cancer is a rapidly evolving field with a transformational impact on early detection, diagnosis, therapeutic development, and personalization of care. Recent advances have greatly increased our understanding of the molecular genomics, proteomics, pathogenesis, and cellular biology of this deadly malignancy. The International Association for the Study of Lung Cancer (IASLC) recently formed a Basic and Translational Science (BaTS) Committee to further enhance the scientific leadership of IASLC in thoracic cancer research. This review by members of the committee highlights the breadth of current research in NSCLC, with a focus on molecular risk factors and processes in tumorigenesis, heterogeneity, phenotypic plasticity, metabolic reprogramming, immunobiology, the immune microenvironment, and microbiome. This review also identifies future research areas that may lead to further improvement in survival outcomes and curative therapies especially for patients with advanced NSCLC. (c) 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Filiaciones:
Mascaux, C:
 Univ Hosp Strasbourg, Dept Pulmonol, Strasbourg, France

 Strasbourg Univ, Inst Natl St & Rech Med INSERM, Unite Mixte Rech UMR 1260, Regenerat Nanomed NanoRegMed, Strasbourg, France

Sen, T:
 Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Oncol Sci, New York, NY USA

:
 Josep Carreras Leukaemia Res Inst IJC, Canc Genet Grp, Barcelona, Barcelona, Spain

Ortiz-Cuaran, S:
 Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Leon Berard, INSERM 1052,CNRS 5286,Canc Res Ctr Lyon, Lyon, France

Bossé, Y:
 Quebec Univ Laval, Inst Univ Cardiol & Pneumol, Quebec City, PQ, Canada

 Univ Laval, Dept Mol Med, Quebec City, PQ, Canada

Dammeijer, F:
 Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands

Cavic, M:
 Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia

Barr, MP:
 Trinity Coll Dublin, Trinity Translat Med Inst, Sch Med, Thorac Oncol Res Grp, Dublin, Ireland

 St James Hosp, Trinity St Jamess Canc Inst, Dublin, Ireland

Arulananda, S:
 Monash Hlth, Dept Med Oncol, Clayton, Australia

Armisen, R:
 Alemana Univ Desarrollo, Fac Med Clin, Ctr Genet & Genom, Santiago, Chile

Berger, AH:
 Fred Hutchinson Canc Ctr, Human Biol Div, Seattle, WA USA

Bianchi, F:
 Fdn Ist Ricovero & Cura Carattere Sci IRCCS Casa S, Unit Canc Biomarkers, San Giovanni Rotondo, Italy

Carbone, DP:
 Ohio State Univ, Dept Med Oncol, Comprehens Canc Ctr, Columbus, OH USA

 Pelotonia Inst Immuno Oncol, Columbus, OH USA

Cerciello, F:
 Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland

Lockwood, WW:
 British Columbia Canc Res Inst, Dept Integrat Oncol, Vancouver, BC, Canada

Mitsudomi, T:
 Izumi City Gen Hosp, Izumi, Japan

 Kindai Univ, Dept Surg, Div Thorac Surg, Higashiosaka, Osaka, Japan

Ohara, S:
 Kindai Univ, Dept Surg, Div Thorac Surg, Higashiosaka, Osaka, Japan

Politi, K:
 Yale Sch Med, Yale Canc Ctr, New Haven, CT USA

Qin, SD:
 Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Thorac Surg, Xian, Shaanxi, Peoples R China

Roisman, LC:
 Samson Assuta Hosp, Canc Res Inst, Ashdod, Israel

 Ben Gurion Univ Negev, Fac Hlth Sci Microbiol & Immunol, Beer Sheva, Israel

Samstein, R:
 Icahn Sch Med Mt Sinai, Dept Radiat Oncol, Dept Immunol & Immunotherapy, New York, NY USA

Skoulidis, F:
 Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA

Tan, AC:
 Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

Thomas, A:
 NCI, Ctr Canc Res, Dev Therapeut Branch, Bethesda, MD USA

Zhang, JJ:
 Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA

Wynes, MW:
 Int Assoc Study Lung Canc, Denver, CO USA

John, T:
 Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Australia

Tsao, MS:
 Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

 Univ Toronto, Dept Lab Med, Dept Med Biophys, Toronto, ON, Canada
ISSN: 15561380





Journal of Thoracic Oncology
Editorial
Elsevier Inc., STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 20 Número: 10
Páginas: 1369-1391
WOS Id: 001592074500002
ID de PubMed: 40473107
imagen Green Submitted

MÉTRICAS